In an adult with idiopathic urticaria refractory to standard doses of non‑sedating H1 antihistamines, is a steroid injection appropriate as rescue therapy?

Steroid Injection for Idiopathic Urticaria

Steroid injections are not recommended as rescue therapy for idiopathic (chronic spontaneous) urticaria refractory to standard-dose antihistamines. The most recent international guidelines explicitly exclude systemic corticosteroids from the treatment algorithm for chronic urticaria, and emerging evidence suggests they may actually prolong disease activity 1, 2.

Why Steroids Are Not Appropriate

Guideline Recommendations Are Clear

• The 2022 international urticaria guidelines provide a stepwise algorithm that does not include corticosteroids at any stage for chronic spontaneous urticaria 1.

• The recommended progression is: (1) standard-dose second-generation H1-antihistamines → (2) updosing antihistamines up to 4-fold → (3) add omalizumab → (4) add ciclosporin 1.

• Oral corticosteroids should be restricted to short courses (3 days to 3-4 weeks) only for severe acute urticaria or specific subtypes like delayed pressure urticaria and urticarial vasculitis 3.

• Long-term oral corticosteroids should not be used in chronic urticaria (Strength of recommendation A) except in very selected cases under regular specialist supervision 3.

Evidence Shows Limited or Negative Benefit

• A 2021 randomized controlled trial found that adding IV dexamethasone to antihistamines did not improve pruritus scores at 60 minutes in acute urticaria 2.

• More concerning, patients who received oral prednisolone for 5 days had more persistent urticaria activity at 1-week and 1-month follow-up compared to those who received antihistamines alone 2.

• While a 2010 retrospective study showed that short-course oral prednisone (25 mg/day for 3 days) induced remission in 47% of antihistamine-resistant patients, this was in the context of chronic urticaria and used oral rather than injectable steroids 4.

What You Should Do Instead

Follow the Evidence-Based Algorithm

Step 1: Optimize antihistamine therapy first 1, 5

• Increase the second-generation H1-antihistamine dose up to 4-fold the standard dose
• This approach achieves well-controlled urticaria in approximately 52% of patients and complete control in 40% 5
• Updosing is more effective than combining multiple different antihistamines 5

Step 2: Add omalizumab if inadequate control after 2-4 weeks 1, 6

• Omalizumab is the only strongly evidence-based alternative for antihistamine-refractory chronic spontaneous urticaria 7
• Dosing: 300 mg every 4 weeks or 600 mg every 2 weeks 1

Step 3: Add ciclosporin if omalizumab fails 1, 3

• Dose: up to 5 mg/kg body weight 1
• Effective in approximately two-thirds of patients with severe autoimmune urticaria 3
• Requires monitoring of blood pressure and renal function every 6 weeks 1

Critical Caveats

When Short-Course Oral Steroids Might Be Considered

Only use oral (not injectable) corticosteroids for:

• Severe acute urticaria with intolerable symptoms (prednisolone 50 mg daily for 3 days, though lower doses often work) 3
• Specific subtypes: delayed pressure urticaria or urticarial vasculitis requiring 3-4 week tapering courses 3

Common Pitfalls to Avoid

• Do not use injectable steroids as "rescue therapy" - there is no evidence supporting this approach and it may worsen long-term outcomes 2
• Do not use steroids to bridge to other therapies - the 2022 guidelines removed this practice from the algorithm 1
• Do not confuse acute urticaria management with chronic spontaneous urticaria - the evidence and recommendations differ significantly 3, 2
• Ensure adequate antihistamine optimization before declaring treatment failure - many patients respond to 4-fold updosing who did not respond to standard doses 5